CXCL10 and cutaneous mastocytosis: We propose that increased expression of CXCL10, a potent anti-angiogenic and apoptotic protein observed in CM patients, contributes to activation and apoptosis in endothelial cells, which perturbs the blood-brain barrier, and subsequently directly or indirectly induces neuroglia apoptosis.